Small Research Kit - Syringes, prep pads and Bac Water Peptide

Research supply kit containing insulin syringes, alcohol prep pads, and bacteriostatic water. Provides the essential accessories needed for peptide reconstitution and handling in laboratory settings. All components are individually sealed and sterile.

The Small Research Kit is a compact bundle of consumable laboratory supplies designed to support standardized reconstitution and aliquoting of lyophilized research peptides. Unlike single-compound peptide products, this kit does not contain an active pharmacological agent; rather, it provides the ancillary materials required to safely dissolve, transfer, and handle peptide solutions under aseptic technique in a research environment.

The typical Small Research Kit includes insulin-grade syringes (commonly 27G–31G, 0.5–1.0 mL barrel), sterile isopropyl alcohol prep pads (70% IPA), and a vial of Bacteriostatic Water for Injection (BWFI) containing 0.9% benzyl alcohol as a bacteriostatic preservative. Together, these components cover the three critical steps of peptide reconstitution: surface sterilization, solvent delivery, and accurate volumetric withdrawal.

This kit is intended strictly for in vitro and laboratory research applications. Reconstitution kits are widely used by research personnel working with growth hormone secretagogues, GLP-1 analogs, repair peptides, and bioregulators, where consistent diluent quality and clean handling directly affect peptide stability, accurate concentration calculations, and downstream assay reproducibility. The 0.9% benzyl alcohol in BWFI suppresses microbial growth across multiple withdrawals, allowing a single reconstituted vial to be sampled over the typical 28-day post-reconstitution working window cited in pharmacopeial guidance for multi-dose preparations.

AminoCore Research supplies the Small Research Kit as an accessory product (Category: Accessories) to complement lyophilized peptide inventory. All components are sourced sterile, single-use, and disposable to minimize cross-contamination risk between research compounds.

Although the Small Research Kit is not a pharmacologically active compound, each component plays a defined chemical and microbiological role in preserving the integrity of lyophilized peptides during reconstitution. Understanding these roles is essential for maintaining experimental reproducibility.

Bacteriostatic Water (0.9% Benzyl Alcohol): Benzyl alcohol functions as a bacteriostatic agent by disrupting microbial membrane integrity and inhibiting enzymatic activity at concentrations of 0.9% w/v. Unlike plain sterile water, which provides no antimicrobial protection once the vial septum is punctured, bacteriostatic water permits multiple withdrawals over an extended period (typically 28 days) while suppressing microbial proliferation. This is critical for research peptides reconstituted at concentrations of 1-10 mg/mL, where partial-volume aliquoting is the norm.

Insulin Syringes (29-31G): The narrow-gauge needle minimizes mechanical shear stress on peptides during withdrawal — an important consideration for high-molecular-weight constructs (e.g., Fc-fusion peptides, PEGylated analogs) where shear-induced aggregation has been documented. The 1-unit (0.01 mL) graduation enables accurate volumetric measurement required for converting reconstituted concentrations to research-relevant doses.

70% Isopropyl Alcohol Prep Pads: 70% IPA is the empirically validated optimum for surface disinfection because it provides sufficient water content to permit protein denaturation in microbial cell walls while still achieving rapid evaporation. Pure (100%) alcohol evaporates too quickly to disinfect, while lower concentrations lack sufficient denaturing activity. Septum disinfection prior to needle insertion reduces the risk of introducing contaminants into both the diluent vial and the peptide vial.

Used together, these components establish an aseptic workflow that minimizes the three principal degradation pathways relevant to reconstituted peptides: microbial contamination, shear-induced aggregation, and oxidative damage from prolonged exposure to non-sterile air.

The Small Research Kit consolidates the essential consumables required for aseptic reconstitution and handling of lyophilized research peptides in a controlled laboratory environment. Each component has been selected to meet the technical demands of milligram- and microgram-scale peptide chemistry, where contamination, oxidation, or improper diluent selection can compromise study reproducibility.

The 0.9% benzyl alcohol content in the bacteriostatic water diluent is the same concentration validated by USP for multi-dose parenteral preparations, providing bacteriostatic activity against common Gram-positive and Gram-negative contaminants while remaining compatible with the majority of peptide backbones used in modern research applications.

The Small Research Kit is designed to support a standardized, aseptic reconstitution workflow for lyophilized peptide vials. The protocol below reflects general best practice for laboratory handling of multi-dose research peptide preparations.

1. Prepare a clean work surface. Wipe the bench with 70% isopropyl alcohol and allow to air dry. Place the lyophilized peptide vial, the Bacteriostatic Water vial, an unopened syringe, and an alcohol prep pad within reach.
2. Sanitize vial stoppers. Tear open one alcohol prep pad and wipe the rubber septum of both the BWFI vial and the peptide vial. Allow 10–15 seconds for the alcohol to evaporate before puncturing.
3. Calculate target concentration. Determine reconstitution volume based on desired concentration. Example: 5 mg lyophilized peptide + 2 mL BWFI = 2.5 mg/mL stock. Use a calibrated calculation rather than visual estimation.
4. Withdraw diluent. Insert the syringe into the BWFI vial, invert, and slowly draw the calculated volume. Tap the barrel to dislodge air bubbles and expel them back into the BWFI vial.
5. Inject diluent into peptide vial. Direct the needle tip against the inner glass wall of the peptide vial and dispense the BWFI slowly down the side — never directly onto the lyophilized cake, which can shear sensitive sequences.
6. Dissolve gently. Swirl or roll the vial between palms. Do not shake or vortex; mechanical agitation can denature peptides and generate foam that complicates accurate withdrawal.
7. Inspect. The reconstituted solution should be clear and free of visible particulates. Cloudiness, precipitate, or persistent foam indicates a handling or solubility issue.

Compound-specific notes: Some peptides (e.g., those containing methionine residues) are oxidation-sensitive — minimize headspace exposure. Disulfide-bonded peptides should not be exposed to reducing agents. Always consult the individual peptide's handling section for sequence-specific cautions.

Each component of the Small Research Kit has distinct storage requirements that affect performance and sterility.

Bacteriostatic Water for Injection (sealed vial): Store at controlled room temperature, 20–25 °C (68–77 °F), protected from light. Do not freeze — freezing can crack the glass vial and compromise the rubber septum seal. Sealed BWFI is stable until the manufacturer's printed expiration date, typically 24 months from production.

Bacteriostatic Water (after first puncture): Pharmacopeial guidance for multi-dose preparations preserved with 0.9% benzyl alcohol typically supports a 28-day in-use period when stored at 2–8 °C (refrigerated) and re-accessed only with sterile syringes through alcohol-prepped septa. Discard after 28 days regardless of remaining volume.

Reconstituted peptide solutions: Once a peptide is dissolved in BWFI, store the vial at 2–8 °C. Working stability for most research peptides reconstituted in BWFI is 14–28 days depending on the specific sequence. For longer storage, prepare aliquots in low-protein-binding tubes and store at −20 °C or −80 °C; avoid repeated freeze-thaw cycles.

Syringes and alcohol prep pads: Store sealed in original packaging at room temperature, away from heat and direct sunlight. Inspect each unit for intact packaging before use; discard any pad that appears dry or any syringe with a damaged barrel or compromised sterile seal. Do not reuse single-use syringes — re-use compromises sterility and needle sharpness, and increases coring risk on rubber septa.